Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
Holding BNGO?
Track your performance easily
BNGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.31 - $3.13
Previous Close$0.42
Volume353.49K
Average Volume (3M)1.83M
Market Cap
$36.09M
Enterprise Value$44.81M
Total Cash (Recent Filing)$18.90M
Total Debt (Recent Filing)$27.57M
Price to Earnings (P/E)―
Beta3.17
Next Earnings
Nov 07, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.01
Shares Outstanding85,997,130
10 Day Avg. Volume1,031,576
30 Day Avg. Volume1,832,283
Standard Deviation0.80
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.45
Price to Sales (P/S)0.97
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.22
Enterprise Value/Gross Profit4.68
Enterprise Value/Ebitda-0.24
Forecast
1Y Price Target
$3.10Price Target Upside638.62% Upside
Rating ConsensusHold
Number of Analyst Covering4
BioNano Genomics News
Bulls Say, Bears Say
Bulls Say
Operational EfficiencyGross margins continue to improve, reaching 33% during the quarter vs. 27% previously, as operating expenses decline significantly due to cost optimization measures.
Regulatory ProgressThe American Medical Association (AMA) has established a category I CPT code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to hematological malignancies.
Technological AdvancementsThe continued rollout and upgrade cycle of BNGO's next-gen, higher-throughput Stratys system.
Bears Say
Revenue GuidanceBionano lowered its 2024 revenue guidance to $32-36M from $36-40M.
Utilization DeclineFlowcell utilization declined 13% y/y to 6,165, representing the first time in 20 consecutive quarters where there was a y/y decline in utilization.
Workforce ReductionBionano will part ways with another 45% of its workforce, expected to reduce its annual cash burn by an additional $25-30M.
---
Ownership Overview
7.04% Insiders
2.92% Mutual Funds
5.26% Other Institutional Investors
84.78% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNGO FAQ
What was BioNano Genomics Inc’s price range in the past 12 months?
BioNano Genomics Inc lowest stock price was $0.30 and its highest was $3.13 in the past 12 months.
What is BioNano Genomics Inc’s market cap?
Currently, no data Available
When is BioNano Genomics Inc’s upcoming earnings report date?
BioNano Genomics Inc’s upcoming earnings report date is Nov 07, 2024 which is in 50 days.
How were BioNano Genomics Inc’s earnings last quarter?
BioNano Genomics Inc released its earnings results on Aug 07, 2024. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.415 by $0.175.
Is BioNano Genomics Inc overvalued?
According to Wall Street analysts BioNano Genomics Inc’s price is currently Undervalued.
Does BioNano Genomics Inc pay dividends?
BioNano Genomics Inc does not currently pay dividends.
What is BioNano Genomics Inc’s EPS estimate?
BioNano Genomics Inc’s EPS estimate is -$0.2.
How many shares outstanding does BioNano Genomics Inc have?
BioNano Genomics Inc has 85,997,130 shares outstanding.
What happened to BioNano Genomics Inc’s price movement after its last earnings report?
BioNano Genomics Inc reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.415. Following the earnings report the stock price went down -6.977%.
Which hedge fund is a major shareholder of BioNano Genomics Inc?
Among the largest hedge funds holding BioNano Genomics Inc’s share is GMT Capital Corp. It holds BioNano Genomics Inc’s shares valued at 360K.
---
BioNano Genomics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.10 (638.62% Upside)
$3.10 (638.62% Upside)
Blogger Sentiment
Neutral
BNGO Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 530.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.07%
12-Months-Change
Fundamentals
Return on Equity
-138.33%
Trailing 12-Months
Asset Growth
-52.33%
Trailing 12-Months
Company Description
BioNano Genomics Inc
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
---
BNGO Earnings Call
Q2 2024
0:00 / 0:00
---
BNGO Stock 12 Month Forecast
Average Price Target
$3.10
▲(638.62% Upside)
Technical Analysis
Best Analysts Covering BNGO
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-56.69%
reiterated a buy rating last month
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -56.69% per trade.
---